NTR Nutrien Ltd.
Nutrien Ltd. provides crop inputs and services. The company operates through four segments: Retail, Potash, Nitrogen, and Phosphate. The Retail segment markets crop nutrients, crop protection products, seed, and merchandise, as well as provides agronomic application and financing services and solutions; and produces proprietary products, including proprietary crop nutrient, crop protection, and seed products. The Potash segment includes mining and processing of potash. The Nitrogen segment owns and operates ammonia production facilities that offers ammonia, urea, ammonium nitrate (UAN), urea solutions, nitric acid, and ammonium nitrate, as well as environmentally smart nitrogen and ammonium sulfate. The Phosphate segment manufactures and sells solid and liquid phosphate fertilizers, phosphate feed, and purified phosphoric acid, which is used in feed and industrial products. The company was incorporated in 2017 and is headquartered in Saskatoon, Canada.…
Industry Peers
Agricultural InputsKey Statistics
About Nutrien (NYSE: NTR)
›
Nutrien (NYSE: NTR) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Agricultural Inputs industry, part of the Basic Materials sector.
The shares were at 65.41 USD on 19 November 2026, up 16.0% over 52 weeks. Its 52-week range is 54.52 USD to 85.36 USD: the price is 23.4% below the high and 20.0% above the low.
At a market capitalisation of 31.01B USD, it trades at 14.3 times trailing earnings and 12.8 times forward earnings. The median trailing P/E of its 11 largest Agricultural Inputs peers is 10.0, a premium of 43% for NTR. It pays a dividend yielding 3.34% (it pays out 48% of its earnings), against a median of 4.27% among the dividend payers in that peer group.
Nutrien reports return on equity of 9.0%, an operating margin of 13.0% and revenue up 1.2% year over year.
Its debt exceeds its cash by 13.20B USD, a debt-to-equity ratio of 0.47. Its Piotroski F-score is 9 out of 9, a strong reading of its financial health. 22 analysts cover the stock, with an average rating of Buy; their mean price target of 77.49 USD is 18.5% above the current price. The next earnings report is expected on 17 February 2027.